KYTX Chart
See on advanced chart >
About
Kyverna Therapeutics, Inc. was incorporated in Delaware in June 2018 under the name BAIT Therapeutics, Inc., and changed their name to Kyverna Therapeutics, Inc. in October 2019. The company is a patient-centered, clinical-stage biopharmaceutical company...
Read More
- HighlightA clinical-stage biopharmaceutical company developing solutions for autoimmune diseases
- ExchangeNASDAQ
- Listing Date02/08/2024
- Established DateInvalid Date
- Full-time Employees96
- Address5980 Horton St. STE 550 Emeryville CA 94608
- Tel1-510-9252492
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology